Evidence map›Paper›PMID 32087834›Full record

ArticleJournal of substance abuse treatment2020

Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs.

Yerina S Ranjit, Roman Shrestha, Michael Copenhaver, Frederick L Altice

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yerina S RanjitDepartment of Communication, University of Missouri, United States of America. Electronic address: ranjity@missouri.edu.
Roman ShresthaDepartment of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University, United States of America.
Michael CopenhaverUniversity of Connecticut, United States of America.
Frederick L AlticeDepartment of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine and Division of Epidemiology of Microbial Diseases, Yale University School of Public Health, United States of America.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Expanding Medication Assisted Therapy in Ukraine (ExMAT)R01DA033679 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2012 to 2021
$6.4M
Enhancing Health Outcomes Among HIV+ Substance AbusersK24DA017072 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2003 to 2012
$1.5M
Optimizing HIV Prevention Among Opioid-Dependent PersonsK24DA051344 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI MICHAEL COPENHAVER · 2020 to 2026
$1.3M
Training in MHealth Prevention with MSMK01DA051346 · NIDA · YALE UNIVERSITY · PI SHRESTHA, ROMAN · 2020 to 2024
$862k
HIV Prevention and Adherence Among Priority Drug Using PopulationsK02DA033139 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI COPENHAVER, MICHAEL · 2013 to 2017
$697k
Improving Antiretroviral Adherence and Persistence using mHealth Tools in HIV-infected Cocaine UsersR21DA039842 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2016 to 2017
$461k
Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs (RAPID)R21DA051934 · NIDA · YALE UNIVERSITY · PI SHRESTHA, ROMAN · 2020 to 2021
$457k
NCATS NIH HHS UL1 TR001863NIDA NIH HHS K01 DA051346NIDA NIH HHS K02 DA033139NIDA NIH HHS K24 DA017072NIDA NIH HHS K24 DA051344NIDA NIH HHS R01 DA033679NIDA NIH HHS R21 DA039842NIDA NIH HHS R21 DA051934
6 · The paper itself

Abstract

People who use drugs (PWUD) remain at high risk for acquiring human immunodeficiency virus (HIV), both from injection and from sexual risk-taking. In 2016, 9% of 39,782 new HIV diagnoses occurred among people who inject drugs in the United States. Reaching PWUD with accurate information about and motivation for initiating pre-exposure prophylaxis (PrEP) remains challenging and remains the first crucial step in the knowledge-attitude-behavior change continuum. This study seeks to contribute to closing this information gap by examining the HIV information-seeking behaviors among PWUD who are not on PrEP, so as to identify potential strategies to increase adoption of HIV prevention such as PrEP as part of overall health and related to risk-taking behaviors. A cross-sectional survey was conducted in 2016 among HIV-negative PWUD (n = 400), 57.3% of whom reported injecting at least once in a week, chronically maintained on methadone treatment (MMT) at a large addiction treatment program. The study found that the number of hours spent online by people who use drugs was comparable to the general population. Awareness about PrEP and the seeking of HIV-related information was low in this population. Looking for sex partners online, perception of risk, having multiple partners were associated with seeking HIV information. Although using injection drugs was related to high perception of risk of acquiring HIV, it was not associated with seeking HIV information online. It is imperative to further understand the online HIV information seeking behavior of this population and provide targeted information in order to increase awareness and knowledge about HIV-related risk and methods of prevention, including information about PrEP.

Indexed as

HIV InfectionsPharmaceutical PreparationsPre-Exposure ProphylaxisSubstance Abuse, IntravenousCross-Sectional StudiesHumansInformation Seeking BehaviorPharmaceutical PreparationsHIV preventionMobile health (mHealth)Online HIV information seeking behaviorPeople who use drugsPrEP

Identifiers

PMID32087834
PMCPMC7039922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.